Skip to main content
TipRanks
Go Ultimate75% OFF

Singapore Institute of Advanced Medicine Holdings Ltd. (9G2) Share Price & Analysis

6 Followers

9G2 Stock Chart & Stats

S$0.02-S$0.00(-4.17%)
At close: 5:00 PM GMT+8
S$0.02S$0.025S$0.03Aug 24Sep 7Sep 21Oct 7Oct 19Nov 2Nov 16
Day’s Range
SGD 0.02 - SGD 0.02
52-Week Range
SGD 0.02 - SGD 0.08
Previous Close
SGD 0.02
Volume
N/A
Average Volume (3M)
1.32M
Market Cap
SGD 41.38M
Enterprise Value
SGD 100.16M
Total Cash (Recent Filing)
SGD 7.24M
Total Debt (Recent Filing)
SGD 59.12M
Price to Earnings (P/E)
―
Beta
-0.14
Next Earnings
Feb 12, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Gross Margin

A gross margin near 92% indicates attractive underlying economics in the company’s specialist healthcare services. If management can control overhead and restore revenue growth, this substantial gross-profit base could provide operating leverage and support a path toward improved profitability.

Improved Leverage

The reduction in leverage from earlier years strengthens financial flexibility relative to the company’s prior position. Positive equity also provides some balance-sheet support, potentially allowing management more time to improve operations, although current leverage remains meaningful.

Narrower Operating Cash Burn

The narrowing operating cash outflow suggests some progress in containing the cash cost of running the business. Continued improvement could reduce reliance on external funding and make the company’s specialist-care platform more resilient while it works toward breakeven.

Bears Say

Material Revenue Decline

The sharp 2026 revenue contraction weakens operating leverage and makes the company’s high fixed-cost burden harder to absorb. Unless revenue stabilizes, the decline can prolong losses, reduce funding capacity, and undermine the ability to scale specialist healthcare operations.

Persistent Deep Losses

Losses remain extremely large relative to revenue, showing that gross profit is currently overwhelmed by overhead and other costs. Persistent unprofitability limits internal funding, depresses returns on equity, and leaves the business dependent on a credible turnaround in cost structure.

Ongoing Negative Cash Generation

Consistently negative operating and free cash flow means the business continues to consume cash rather than fund itself. Even with some improvement in operating burn, sustained outflows increase funding risk and can constrain investment in clinical services and future growth.

Singapore Institute of Advanced Medicine Holdings Ltd. News

9G2 FAQ

What was Singapore Institute of Advanced Medicine Holdings Ltd.’s price range in the past 12 months?
Singapore Institute of Advanced Medicine Holdings Ltd. lowest share price was S$0.02 and its highest was S$0.08 in the past 12 months.
What is Singapore Institute of Advanced Medicine Holdings Ltd.’s market cap?
Singapore Institute of Advanced Medicine Holdings Ltd.’s market cap is S$41.38M.
When is Singapore Institute of Advanced Medicine Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Singapore Institute of Advanced Medicine Holdings Ltd.’s earnings last quarter?
Singapore Institute of Advanced Medicine Holdings Ltd. released its earnings results on Nov 08, 2026. The company reported -S$0.003 earnings per share for the quarter.
Is Singapore Institute of Advanced Medicine Holdings Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Singapore Institute of Advanced Medicine Holdings Ltd. pay dividends?
Singapore Institute of Advanced Medicine Holdings Ltd. does not currently pay dividends.
What is Singapore Institute of Advanced Medicine Holdings Ltd.’s EPS estimate?
Singapore Institute of Advanced Medicine Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Singapore Institute of Advanced Medicine Holdings Ltd. have?
Singapore Institute of Advanced Medicine Holdings Ltd. has 1,724,092,500 shares outstanding.
What happened to Singapore Institute of Advanced Medicine Holdings Ltd.’s price movement after its last earnings report?
Singapore Institute of Advanced Medicine Holdings Ltd. reported an EPS of -S$0.003 in its last earnings report. Following the earnings report the stock price went down -6.522%.
Which hedge fund is a major shareholder of Singapore Institute of Advanced Medicine Holdings Ltd.?
Currently, no hedge funds are holding shares in SG:9G2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology